165 related articles for article (PubMed ID: 15233285)
21. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Howman-Giles R; Uren RF; Shaw PJ
J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
[TBL] [Abstract][Full Text] [Related]
22. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
Hsu CC; Chen YW; Huang YF; Chuang YW
Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
[TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
24. Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy.
Ohnishi T; Noguchi S; Murakami N; Jinnouchi S; Hoshi H; Futami S; Watanabe K
AJNR Am J Neuroradiol; 1993; 14(5):1051-7. PubMed ID: 8237680
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
26. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
[TBL] [Abstract][Full Text] [Related]
27. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
28. Intense 201 Tl uptake in giant-cell tumour of bone.
Higuchi T; Taki J; Sumiya H; Kinuya S; Bunko H; Nonomura A; Tsuchiya H; Tonami N
Nucl Med Commun; 2002 Jun; 23(6):595-9. PubMed ID: 12029217
[TBL] [Abstract][Full Text] [Related]
29. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
30. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
[TBL] [Abstract][Full Text] [Related]
31. Thallium-201 scintigraphy of neuroblastoma: different results for primary tumors and skeletal lesions.
Okuyama C; Ushuima Y; Nakamura T; Kikkawa M; Nishimura T
Ann Nucl Med; 2001 Apr; 15(2):171-7. PubMed ID: 11448079
[TBL] [Abstract][Full Text] [Related]
32. The cause and clinical significance of central tumor photopenia on thallium scintigraphy of pediatric osteosarcoma of the extremity.
McCarville MB; Barton EH; Cameron JR; Xiong X; Daw NC; Kaste SC; Wu S; Glass JO; Reddick WE
AJR Am J Roentgenol; 2007 Feb; 188(2):572-8. PubMed ID: 17242270
[TBL] [Abstract][Full Text] [Related]
33. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphy.
Watanabe N; Shimizu M; Kageyama M; Tanimura K; Kinuya S; Shuke N; Yokoyama K; Tonami N; Watanabe A; Seto H; Goodwin DA
J Nucl Med; 1999 Jul; 40(7):1138-42. PubMed ID: 10405133
[TBL] [Abstract][Full Text] [Related]
35. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors.
Caluser C; Macapinlac H; Healey J; Ghavimi F; Meyers P; Wollner N; Kalaigian J; Kostakoglu L; Abdel-Dayem HM; Yeh SD
Clin Nucl Med; 1992 Jul; 17(7):565-72. PubMed ID: 1638838
[TBL] [Abstract][Full Text] [Related]
36. The role of nuclear medicine in primary bone and soft tissue tumors.
Abdel-Dayem HM
Semin Nucl Med; 1997 Oct; 27(4):355-63. PubMed ID: 9364645
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-depreotide in the evaluation of bone infection and inflammation.
Papathanasiou ND; Rondogianni PE; Pianou NK; Karampina PA; Vlontzou EA; Datseris IE
Nucl Med Commun; 2008 Mar; 29(3):239-46. PubMed ID: 18349794
[TBL] [Abstract][Full Text] [Related]
38. [Clinical usefulness of 201Tl-chloride scintigraphy for the diagnosis of bone metastases].
Koyama M
Kaku Igaku; 1995 Jan; 32(1):9-18. PubMed ID: 7897873
[TBL] [Abstract][Full Text] [Related]
39. Will thallium-201 replace gallium-67 in salivary gland scintigraphy?
Arbab AS; Koizumi K; Hiraike S; Toyama K; Arai T; Araki T
J Nucl Med; 1996 Nov; 37(11):1819-23. PubMed ID: 8917182
[TBL] [Abstract][Full Text] [Related]
40. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
